BioCentury
ARTICLE | Company News

Apeiron Biologics, Evotec deal

November 1, 2010 7:00 AM UTC

Evotec will use its preclinical screening technologies and assay development to evaluate small molecule modulators of downstream regulatory element antagonistic modulator (DREAM) discovered by Apeiro...